Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-01-01 @ 12:38 PM
Study NCT ID:
NCT06344169
Status:
RECRUITING
Last Update Posted:
2025-05-09
First Post:
2024-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section
Sponsor:
Dalin Tzu Chi General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-14
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-27
First Submit QC Date:
None
Study First Post Date:
2024-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-06
Last Update Post Date:
2025-05-09
Last Update Post Date Type:
ACTUAL